Nina Herne
Corporate Officer/Principal bei Newron Sweden AB
Profil
Nina Herne is currently working as a Projects Director at Newron Sweden AB.
Previously, she served as the Chief Executive Officer at LIDDS AB from 2021 to 2022.
She also worked as a Project Manager at Novozymes A in 2002 and at Affibody AB from 2002 to 2008.
Additionally, she held the position of Chief Development Officer at Vivesto AB.
Dr. Herne holds an MBA from Stockholm School of Economics and a doctorate from the University of Lund.
Aktive Positionen von Nina Herne
| Unternehmen | Position | Beginn |
|---|---|---|
Newron Sweden AB
 Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Nina Herne
| Unternehmen | Position | Ende |
|---|---|---|
| LIDDS AB | Vorstandsvorsitzender | 01.09.2022 |
Affibody AB
 Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Corporate Officer/Principal | 01.01.2008 |
Novozymes A/S
 Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | 01.01.2002 |
| VIVESTO AB | Corporate Officer/Principal | - |
Ausbildung von Nina Herne
| University of Lund | Doctorate Degree |
| Stockholm School of Economics | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| LIDDS AB | Health Technology |
| VIVESTO AB | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Newron Sweden AB
Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Health Technology |
Affibody AB
Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Commercial Services |
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark. | Process Industries |
